Next-generation trial shows five-drug combo can keep 'ultra-high-risk' bone marrow cancer at bay

byInstitute of Cancer ResearchImmunofluorescent image of autophagosomes in multiple myeloma cells. Credit: Institute of Cancer ResearchCombining five existing drugs can keep a highly aggressive

Updated on: January 15,2024

Next-generation trial shows five-drug combo can keep 'ultra-high-risk' bone marrow cancer at bay

byInstitute of Cancer ResearchImmunofluorescent image of autophagosomes in multiple myeloma cells. Credit: Institute of Cancer ResearchCombining five existing drugs can keep a highly aggressive

Updated on:January 15,2024

Endometrial cancer: New insights into a deadly disparity

byMemorial Sloan Kettering Cancer CenterCredit: Pixabay/CC0 Public DomainEndometrial cancer—which develops in the lining of the uterus (womb) and is sometimes called uterine cancer—is on the ris

Updated on: December 28,2023

Endometrial cancer: New insights into a deadly disparity

byMemorial Sloan Kettering Cancer CenterCredit: Pixabay/CC0 Public DomainEndometrial cancer—which develops in the lining of the uterus (womb) and is sometimes called uterine cancer—is on the ris

Updated on:December 28,2023

Researchers create a drug to extend the lives of men with prostate cancer

by Stuart Wolpert,University of California, Los AngelesMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Fifteen ye

Updated on: June 24,2024

Researchers create a drug to extend the lives of men with prostate cancer

by Stuart Wolpert,University of California, Los AngelesMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Fifteen ye

Updated on:June 24,2024

Researchers find a new class of biomarkers to predict treatment outcomes in cancer patients

by Kathryn F. Sykes , Medical XpressCancer is the result of the uncontrolled division and spread of cells into surrounding tissue. Recently researchers have begun to focus on biomarkers as a source of

Updated on: January 30,2024

Researchers find a new class of biomarkers to predict treatment outcomes in cancer patients

by Kathryn F. Sykes , Medical XpressCancer is the result of the uncontrolled division and spread of cells into surrounding tissue. Recently researchers have begun to focus on biomarkers as a source of

Updated on:January 30,2024

Existing cancer drug ponatinib could be repurposed to fight certain aggressive cancers

byNanyang Technological UniversitySchematic summary of mechanisms of action of ponatinib in ALT cells. Ponatinib disrupts alternative lengthening of telomeres mechanisms by inducing telomeric C-

Updated on: January 10,2024

Existing cancer drug ponatinib could be repurposed to fight certain aggressive cancers

byNanyang Technological UniversitySchematic summary of mechanisms of action of ponatinib in ALT cells. Ponatinib disrupts alternative lengthening of telomeres mechanisms by inducing telomeric C-

Updated on:January 10,2024

Common hair loss and prostate drug may also cut heart disease risk

by Lauren Quinn,University of Illinois at Urbana-ChampaignFinasteride decreases plaque size and macrophage content in Ldlr-/-mice. Four-week-old male Ldlr-/-mice were fed Western die

Updated on: March 25,2024

Common hair loss and prostate drug may also cut heart disease risk

by Lauren Quinn,University of Illinois at Urbana-ChampaignFinasteride decreases plaque size and macrophage content in Ldlr-/-mice. Four-week-old male Ldlr-/-mice were fed Western die

Updated on:March 25,2024

Pancreatic cancer tumor map uncovers notable differences between primary and metastatic disease

by Candace Gwaltney,Indiana UniversityIdentification of pancreatic cancer architecture. Credit:Nature Genetics(2024). DOI: 10.1038/s41588-024-01914-4Indiana University Melvin and Bre

Updated on: November 11,2024

Pancreatic cancer tumor map uncovers notable differences between primary and metastatic disease

by Candace Gwaltney,Indiana UniversityIdentification of pancreatic cancer architecture. Credit:Nature Genetics(2024). DOI: 10.1038/s41588-024-01914-4Indiana University Melvin and Bre

Updated on:November 11,2024

Study provides new insights for ways to use cell metabolism to treat cancer

by Katie Pence,University of Cincinnati Academic Health CenterResearchers at the University of Cincinnati (UC) College of Medicine have discovered that cell metabolism plays an important role in

Updated on: April 18,2024

Study provides new insights for ways to use cell metabolism to treat cancer

by Katie Pence,University of Cincinnati Academic Health CenterResearchers at the University of Cincinnati (UC) College of Medicine have discovered that cell metabolism plays an important role in

Updated on:April 18,2024

Mouth cancer cases hit new record in England and Scotland—what you need to know

by Justin Stebbing,The ConversationCredit: Pixabay/CC0 Public DomainCases of mouth cancer have reached a record high in England and Scotland, a newreport shows. Last year, there were more

Updated on: November 30,2024

Mouth cancer cases hit new record in England and Scotland—what you need to know

by Justin Stebbing,The ConversationCredit: Pixabay/CC0 Public DomainCases of mouth cancer have reached a record high in England and Scotland, a newreport shows. Last year, there were more

Updated on:November 30,2024

Scientists enhance cell-based therapy to destroy solid tumors

byThe Wistar InstituteGraphical abstract. Credit:Molecular Therapy - Oncolytics(2023). DOI: 10.1016/j.omto.2023.100744Wistar researchers successfully tested a simple intervention tha

Updated on: January 25,2024

Scientists enhance cell-based therapy to destroy solid tumors

byThe Wistar InstituteGraphical abstract. Credit:Molecular Therapy - Oncolytics(2023). DOI: 10.1016/j.omto.2023.100744Wistar researchers successfully tested a simple intervention tha

Updated on:January 25,2024

Avelumab plus axitinib significantly improve progression-free survival in untreated renal cell carcinoma

byEuropean Society for Medical OncologyCredit: CC0 Public DomainA combination of the immune checkpoint blocker, avelumab, plus the tyrosine kinase inhibitor (TKI), axitinib, significantly improv

Updated on: December 18,2023

Avelumab plus axitinib significantly improve progression-free survival in untreated renal cell carcinoma

byEuropean Society for Medical OncologyCredit: CC0 Public DomainA combination of the immune checkpoint blocker, avelumab, plus the tyrosine kinase inhibitor (TKI), axitinib, significantly improv

Updated on:December 18,2023

Prognosis of multiple myeloma has improved since 2000

by Elana GotkineFor patients with multiple myeloma (MM), there has been an improvement in prognosis since 2000, but mortality still remains elevated, according to a study published online April 6 in&n

Updated on: January 22,2024

Prognosis of multiple myeloma has improved since 2000

by Elana GotkineFor patients with multiple myeloma (MM), there has been an improvement in prognosis since 2000, but mortality still remains elevated, according to a study published online April 6 in&n

Updated on:January 22,2024